Creation and Validation of a Portuguese Version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
Authors:
- Pedro L. FerreiraPFPedro L. Ferreira
- Inês GenrinhoIGInês Genrinho
- Tânia SantiagoTSTânia Santiago
- Adriana CaronesACAdriana Carones
- Carolina MazedaCMCarolina Mazeda
- Anabela BarcelosABAnabela Barcelos
- Tiago BeirãoTBTiago Beirão
- Flávio CostaFCFlávio Costa
- Inês SantosISInês Santos
- Maura CoutoMCMaura Couto
- Maria RatoMRMaria Rato
- Georgina TerrosoGTGeorgina Terroso
Open Access
- 14 January 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (2) , 1553
Abstract
(1) Background: The UCLA GIT 2.0 questionnaire has been recognized as a feasible and reliable instrument to assess gastrointestinal (GI) symptoms in systemic sclerosis (SSc) patients and their impact on quality of life. The aim of this study was to create and validate UCLA GIT 2.0 for Portuguese patients with SSc. (2) Methods: A multi-center study was conducted enrolling SSc patients. UCLA GIT 2.0 was validated in Portuguese using reliability (internal consistency, item –total correlation, and reproducibility) and validity (content, construct, and criterion) tests. Criterion tests included EQ-5D and SF-36v2. Social–demographic and clinical data were collected. (3) Results: 102 SSc patients were included, 82.4% of them female, and with a mean sample age of 57.0 ± 12.5 years old. The limited form of SSc was present in 62% of the patients and 56.9% had fewer than five years of disease duration. Almost 60% presented with SSc-GI involvement with a negative impact on quality of life. The means for SF-36v2 were 39.3 ± 10.3 in the physical component summary and 47.5 ± 12.1 in the mental component summary. Total GI score, reported as mild in 57.8% of the patients, was highly reliable (ICC = 0.912) and the Cronbach’s alpha was 0.954. There was a high correlation between the total GI score and EQ-5D-5L and SF-36v2 scores. (4) Conclusion: The Portuguese version of UCLA GIT 2.0 showed good psychometric properties and can be used in research and clinical practice.Keywords
Funding Information
- Multiannual Financing of R&D Units (2020–2023)
This publication has 34 references indexed in Scilit:
- Measuring response in the gastrointestinal tract in systemic sclerosisCurrent Opinion in Rheumatology, 2013
- Gastrointestinal complications of systemic sclerosisWorld Journal of Gastroenterology, 2013
- Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentThe Journal of Rheumatology, 2011
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupAnnals of the Rheumatic Diseases, 2011
- The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomesJournal of Clinical Epidemiology, 2010
- Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centreRheumatology, 2010
- Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrumentArthritis Care & Research, 2009
- Linguistic Validation Manual for Patient-Reported Outcomes (PRO) Instruments, By C. Acquadro, K. Conway, C. Girourdet & I. Mear, MAPI ResearchTrust, Lyon, France, 2004,184 pp, ISBN: 2-9522021-0-9, price €70/$90.Quality of Life Research, 2005
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992